P(CH2CH2Py)nPh3-n Ligands for Palladium
Inorganic Chemistry, Vol. 36, No. 23, 1997 5255
Synthesis of the Complexes. [PdCl(C6Cl2F3)(PN)] (1). To a
stirred solution of [Pd2(µ-Cl)2(C6Cl2F3)2(tht)2] (106.6 mg, 0.134 mmol)
in CH2Cl2 (20 mL) was added PN (78 mg, 0.268 mmol) in 10 mL of
CH2Cl2. After 30 min, the pale yellow solution was filtered, 15 mL of
ethanol was added, and the solution was concentrated to 10 mL. After
the concentrate was allowed to stand overnight at -20 °C, 1 crystallized
as a white product, which was filtered off and dried in vacuum.
Yield: 129 mg (76%). Anal. Calcd: C, 47.42; N, 2.21; H, 2.86.
Found: C, 46.85; N, 2.00; H, 3.05. 1H NMR (CDCl3): δ 9.25 (d,
1H), 7.76 (td, 1H), 7.30 (m, 12H), 3.71 (m, 2H), 2.60 (m, 2H).
Table 4. Crystal Data and Structure Refinement Details for
[Pd(C6Cl2F3){µ-P(C2H4Py)2PhP,N,µ-N′}]2(BF4)2‚CH3CN (7)
empirical formula
fw
C58H45B2Cl4F14N5P2Pd2
1516.2
crystal size, mm
crystal system
0.4 × 0.37 × 0.60
triclinic
space group
a, Å
b, Å
c, Å
P1h (No. 2)
10.972(2)
11.113(2)
12.898(3)
70.55(1)
88.39(1)
75.13(1)
1430.4(5)
1
1.76
0.960
2.39-25.09
6844
4858 [R(int) ) 0.0973]
0.0775, 0.1857
1.088
R, deg
[Pd(C6F5)Cl(PN)] (2). To a stirred solution of [Pd2(µ-Cl)2-
(C6F5)2(tht)2] (100 mg, 0.126 mmol) in CH2Cl2 (20 mL) was added
PN (74 mg, 0.254 mmol) in 10 mL of CH2Cl2. After 30 min, the
solution was filtered and evaporated to dryness. The resulting oil was
washed twice with 10 mL of n-hexane to remove the remaining tht,
and the product 2 was crystallized from CH2Cl2/ethanol. Yield: 131
mg (87%). Anal. Calcd: C, 50.05; N, 2.33; H, 3.00. Found: C, 50.12;
N, 2.41; H, 2.88. 1H NMR (CDCl3): δ 9.22 (d, 1H), 7.65 (td, 1H),
7.3 (m, 12H), 3.67 (m, 2H), 2.52 (m, 2H).
â, deg
γ, deg
V, Å3
Z
F(calcd), Mg m-3
µ, mm-1
θ range, deg
no. of collcd reflecns
no. of reflecns for calcns
final R1, wR2a
goodness-of-fit, Sa
max peak in final diff map, e Å-3
[Pd(C6Cl2F3)Cl(PN2)] (3). This compound was prepared as de-
scribed for 1, but using PN2 (85.8 mg, 0.268 mmol) instead of PN.
Yield: 142 mg (81%). Anal. Calcd: C, 47.16; N, 4.23; H, 3.20.
Found: C, 47.02; N, 4.11; H, 3.31. 1H NMR (CDCl3 at 213 K): δ
9.28 (d, coord Py, 1H), 8.48 (d, free Py, 1H), 7.83 (m, 1H) 7.63 (m,
1H), 7.28-7.60 (m, 7H), 7.17 (dd, 1H), 6.99 (d, 1H), 3.60 (broad m,
2H), 2.95 (broad m, 1H), 2.45 (broad m, 2H), 2.27 (broad m, 3H).
2.33
a Residuals calculated for reflections with I > 2σ(I); wR2 ) [∑w∆2/
4
∑wFo ]0.5; S ) [∑w∆2/(N - NV)]0.5; R1 ) ∑||Fo| - |Fc||/∑|Fo|; ∆ )
2
Fo - Fc2.
7.65 (m, 2H), 7.55 (d, 1H), 7.31 (m, 2H), 7.17 (m, 2H), 4.99 (broad
m, 1H), 3.50 (broad m, 4H), 3.37 (m, 2H), 2.60 (m, 2H), 2.58 (m,
3H).
[Pd(C6F5)Cl(PN2)] (4). This compound was prepared as described
for 2, but using PN2 (81.4 mg, 0.254 mmol) instead of PN. Yield:
105 mg (66%). Anal. Calcd: C, 47.71; N, 4.45; H, 3.33. Found: C,
47.68; N, 4.35; H, 3.41. 1H NMR (CDCl3 at 213 K): δ 9.29 (d, coord
Py, 1H), 8.45 (free Py, 1H), 7.83 (m, 1H), 7.62 (m, 1H), 7.49 (dd,
2H), 7.36 (m, 5H), 7.17 (dd, 1H), 7.00 (d, 1H), 3.58 (broad m, 2H),
2.97 (broad m, 1H), 2.40 (broad m, 3H), 2.25 (broad m, 2H).
[Pd2(C6F5)2(PN3)2](BF4)2 (10). This compound was prepared as
described for 8, but starting from 6 (110 mg, 0.18 mmol) instead of 4.
Yield: 95 mg (78%). Anal. Calcd: C, 45.71; N, 5.95; H, 3.38.
Found: C, 45.82; N, 6.01; H, 3.49. 1H NMR (243 K, CD3CN): δ
8.53 (d, 1H), 8.38 (dd, 1H), 7.95 (m, 2H), 7.82 (t, 1H), 7.65 (m, 3H),
7.35 (t, 1H), 7.24 (t, 1H), 7.17 (m, 2H), 4.94 (broad m, 1H), 3.60-3.1
(broad m, 5H), 2.65 (m, 2H), 2.48 (m, 1H), 2.07 (m, 3H).
Equilibrium between 7 and 8. Complexes 7 (10.4 mg, 0.0073
mmol) and 8 (9.9 mg, 0.0073 mmol) were dissolved in 0.5 mL of CD3-
CN in an NMR tube. The 19F NMR spectrum at room temperature
showed the signals of the complex [Pd2(C6F5)(C6Cl2F3)(PN2)2](BF4)2
(11). 19F NMR (acetone-d6): δ(C6F3Cl2 group), -88.85 (d, 3JF-P ) 8
Hz, 1F), -89.1 (t, 1F), -117.45 (s, 1F); δ(C6F5 group) -112.02 (m,
1F), -116.71 (m, 1F), -159.50 (t, 1F), -159.85 (m, 1F), -162.32
(m, 1F).
Equilibrium between 9 and 10. Complexes 9 (17.4 mg, 0.0117
mmol) and 10 (16.6 mg, 0.0117 mmol) were dissolved in 0.6 mL of
CD3CN in an NMR tube. The 19F NMR spectrum at 243 K showed
signals (1:1:2 ratio) for complexes 9 and 10 and for [Pd2(C6F5)(C6-
Cl2F3)(PN3)2](BF4)2 (12). 19F NMR (CD3CN) for 12: δ(C6F3Cl2 group)
-88.41 (broad, 1F), -88.53 (broad d, 1F), -117.12 (s, 1F); δ(C6F5
group) -111.40 (m, 1F), -116.49 (m, 1F), -158.7 (m, 1F), -159.18
(m, 1F), -161.21 (m, 1F).
X-ray Structure of [Pd2(C6Cl2F3)2{µ-PPh(C2H4Py)2-P,N,µ-N′}2]-
(BF4)2‚CH3CN (7). Crystal data and other details of the structure
analysis are presented in Table 4. Colorless crystals of 7 were
recrystallized from an acetonitrile/2-propanol/ether solution and showed
a regular blocklike habit. The mother liquors, as well as the crystals,
showed signs of decomposition, yielding metallic palladium. The
crystals showed signs of partial decomposition of the crystal, reflected
in broad diffraction peaks and high-background scattered radiation. After
checking a number of crystals, we selected one with approximate
dimensions of 0.4 × 0.37 × 0.60 mm for study and mounted it on a
glass fiber with vacuum grease.
All diffraction measurements were made at -100 °C with a Siemens
three-circle SMART29 area detector diffractometer using graphite-
monochromated Mo KR radiation. Unit cell dimensions were deter-
mined from reflections taken from three sets of 30 frames (at 0.3° steps
in ω), each at 10 s exposure. A full hemisphere of reciprocal space
(1321 frames in total, 10 s exposure per frame) was scanned by 0.3° ω
[Pd(C6Cl2F3)Cl(PN3)]‚0.5 CH2Cl2 (5). This compound was pre-
pared as described for 1, but using PN3 (93.6 mg, 0.268 mmol) instead
of PN. Yield: 149 mg (81%). Anal. Calcd: C, 45.15; N, 5.74; H,
3.42. Found: C, 45.23; N, 5.80; H, 3.52. 1H NMR (CDCl3 at -60
°C): δ 9.32 (coord Py, 1H), 8.43 (free Py, 2H), 7.78 (m, 1H), 7.62 (m,
2H), 7.2-7.4 (m, 2H), 7.11 (m, 4H), 3.35 (broad m, 2H), 3.22 (broad
m, 2H), 2.68 (broad m, 2H), 2.09 (broad m, 2H), 1.65 (broad m, 4H).
[Pd(C6F5)Cl(PN3)] (6). This compound was prepared as described
for 1, but using PN3 (88.7 mg, 0.254 mmol) instead of PN. Yield:
125 mg (75%). Anal. Calcd: C, 49.28; N, 6.41; H, 3.65. Found: C,
49.14; N, 6.33; H, 3.47. 1H NMR (-213 K, CDCl3): δ 9.40 (dd, coord
Py, 1H), 8.43 (dd, free Py, 2H), 7.87 (t, coord Py, 1H), 7.63 (t, free
Py, 2H), 7.38 (m, coord Py, 2H), 7.15 (m, free Py, 4H), 3.28 (broad
m, free CH2CH2Py, 4H), 2.71 (broad m, coord CH2CH2Py, 2H), 2.12
(broad m, coord CH2CH2Py, 2H), 1.89 (broad m, free CH2CH2Py, 4H).
[Pd2(C6Cl2F3)2(PN2)2](BF4)2 (7). To a stirred solution of 3 (111.2
mg, 0.168 mmol) in acetone (30 mL) was added AgBF4 (33 mg, 0.168
mmol). After 30 min, the AgCl formed was removed by filtration.
Addition of ethanol (15 mL) and evaporation gave a white precipitate,
which was filtered off and dried in vacuum. Yield: 97 mg (81%).
Anal. Calcd: C, 43.76; N, 3.93; H, 2.97. Found: C, 43.63; N, 3.75;
H, 3.07. 1H (acetone-d6): 8.8 (broad d, coord Py, 1H), 8.4 (t, bridging
Py, JF-H ) 4.8 Hz, 1H), 8.19 (td, 1H), 8.08 (td, 1H), 7.83 (ddd, 2H),
7.74 (dd, 2H), 7.52 (m, 3H), 7.38 (m, 2H), 5.41 (broad m, 1H), 3.98
(broad m, 3H), 3.48 (m, 1H), 3.30 (m, 1H), 2.63 (m, 2H).
[Pd2(C6F5)2(PN2)2](BF4)2 (8). This compound was prepared as
described for 7, but starting from 4 (106 mg, 0.168 mmol) instead of
3. Yield: 80 mg (70%). Anal. Calcd: C, 45.88; N, 4.16; H, 2.79.
Found: C, 45.59; N, 4.06; H, 2.58. 1H (acetone-d6): 8.92 (broad d,
coord Py, 1H), 8.35 (t, bridging Py, JF-H ) 4.1 Hz, 1H), 8.21 (td, 1H),
8.11 (td, 1H), 7.80 (ddd, 2H), 7.70 (dd, 2H), 7.49 (m, 3H), 7.35 (m,
2H), 5.40 (broad m, 1H), 3.90 (broad m, 3H), 3.47 (m, 1H), 3.30 (m,
1H), 2.58 (m, 2H).
[Pd2(C6Cl2F3)2(PN3)2](BF4)2 (9). This compound was prepared as
described for 7, but starting from 5 (110 mg, 0.168 mmol) instead of
3. Yield: 73 mg (61%). Anal. Calcd: C, 44.77; N, 5.80; H, 3.31.
Found: C, 44.63; N, 5.74; H, 3.45. 1H NMR (243 K, CD3CN): δ
8.45 (d, 1H), 8.36 (dd, 1H), 7.96 (t, 1H), 7.93 (t, 1H), 7.82 (t, 1H),
(29) SMART Siemens Molecular Analysis Research Tool V4.014, Siemens
Analytical X-ray Instruments, Madison, WI.